Evidence map›Paper›PMID 37389810›Full record

ArticleAnalytical chemistry2023

Evaluation of the Orbitrap Ascend Tribrid Mass Spectrometer for Shotgun Proteomics.

Yuchen He, Evgenia Shishkova, Trenton M Peters-Clarke, Dain R Brademan, Michael S Westphall, David Bergen, Jingjing Huang, Romain Huguet, Michael W Senko, Vlad Zabrouskov and 2 more

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. UnderstandingJournal of the American Society for Mass Spectrometry · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Protein cleaver: an interactive web interface forFrontiers in bioinformatics · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yuchen HeDepartment of Biomolecular Chemistry, University of Wisconsin─Madison, Madison, Wisconsin 53706, United States.ORCID 0000-0002-6096-4915
Evgenia ShishkovaDepartment of Biomolecular Chemistry, University of Wisconsin─Madison, Madison, Wisconsin 53706, United States.ORCID 0000-0001-6097-6097
Trenton M Peters-ClarkeDepartment of Chemistry, University of Wisconsin─Madison, Madison, Wisconsin 53706, United States.ORCID 0000-0002-9153-2525
Dain R BrademanMorgridge Institute for Research, Madison, Wisconsin 53715, United States.
Michael S WestphallDepartment of Biomolecular Chemistry, University of Wisconsin─Madison, Madison, Wisconsin 53706, United States.
David BergenThermo Fisher Scientific, San Jose, California 95134, United States.
Jingjing HuangThermo Fisher Scientific, San Jose, California 95134, United States.
Romain HuguetThermo Fisher Scientific, San Jose, California 95134, United States.
Michael W SenkoThermo Fisher Scientific, San Jose, California 95134, United States.
Vlad ZabrouskovThermo Fisher Scientific, San Jose, California 95134, United States.ORCID 0000-0003-3567-9407
Graeme C McAlisterThermo Fisher Scientific, San Jose, California 95134, United States.
Joshua J CoonDepartment of Biomolecular Chemistry, University of Wisconsin─Madison, Madison, Wisconsin 53706, United States.ORCID 0000-0002-0004-8253
Thermo Fisher Scientific (United States) · USUniversity of Wisconsin–Madison · USMorgridge Institute for Research · US

Funding

Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
TR&D 2 Metabolic Labels for Ultraplexed Protein Quantification p. 453P41GM108538 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI COON, JOSHUA J · 2016 to 2025
$13.1M
NHGRI NIH HHS T32 HG002760NIGMS NIH HHS P41 GM108538
6 · The paper itself

Abstract

Mass spectrometry (MS)-based proteomics is a powerful technology to globally profile protein abundances, activities, interactions, and modifications. The extreme complexity of proteomics samples, which often contain hundreds of thousands of analytes, necessitates continuous development of MS techniques and instrumentation to improve speed, sensitivity, precision, and accuracy, among other analytical characteristics. Here, we systematically evaluated the Orbitrap Ascend Tribrid mass spectrometer in the context of shotgun proteomics, and we compared its performance to that of the previous generation of Tribrid instruments─the Orbitrap Eclipse. The updated architecture of the Orbitrap Ascend includes a second ion-routing multipole (IRM) in front of the redesigned C-trap/Orbitrap and a new ion funnel that allows gentler ion introduction, among other changes. These modifications in Ascend hardware configuration enabled an increase in parallelizable ion injection time during higher-energy collisional dissociation (HCD) Orbitrap tandem MS (FTMS

Indexed as

ProteinsProteomicsHEK293 CellsHumansPhosphopeptidesTandem Mass SpectrometryPhosphopeptidesProteins

Identifiers

PMID37389810
PMCPMC10528367
OpenAlexW4382631287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.